Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/1999
03/30/1999US5888791 Metabolites in culture
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888770 Spoiiie
03/30/1999US5888551 Stimulating hair growth by applying a medium containing hair growth-stimulating activity or factors obtained from a cell culture of human mononuclear cells
03/30/1999US5888520 Composition, barrier film, and method for preventing contact dermatitis
03/30/1999US5888494 Topical
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1999013885A1 Modulation of immune responses
03/25/1999WO1999013857A1 Aqueous solutions of salicylic acid derivatives
03/25/1999WO1999013856A1 Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation
03/25/1999WO1999013853A1 Triple emulsion containing a solar protecting system
03/25/1999WO1999013819A2 Composition and method for reducing stinging in skin
03/25/1999WO1999013717A1 A delivery of arginine to cause beneficial effects
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999WO1998050032A9 BETA-LACTAM INHIBITORS OF CoA-IT
03/25/1999DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2303141A1 Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation
03/25/1999CA2244971A1 Mure
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903349A2 CCR-3 receptor antagonists
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903145A2 Pharmaceutical composition for skin disorders
03/24/1999EP0902680A1 Reparation and prevention of fibrotic lesions
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999CN1211938A Solid and semi-solid hydrocarbon gels and use thereof
03/24/1999CN1211925A Use of ginkgo biloba extracts for preparation of pharmaceutical compositions and method of cosmetic treatment using ginkgo biloba extract
03/24/1999CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists
03/24/1999CN1211420A 洗澡剂 Bathing agent
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886053 Use of carotenoids for producing drugs for the treatment of dermatoses
03/23/1999US5886042 Amphoteric compostion and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886041 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5885982 Use of transglutaminase inhibitor for the treatment of scar tissue
03/23/1999US5885978 External therapeutic composition for dermatitis
03/23/1999US5885960 Method of treatment comprising administering a combination comprising FGF and polyelectrolytes
03/23/1999US5885595 Treating skin disorder with acne, follicular and lesional papules, actinic keratoses, oily skin and rosacea
03/23/1999US5885582 Extract from the leaves of ginkgo biloba
03/23/1999US5885557 Topical mixture of 1,3-dihydroxyacetone, a penetration attenuator and a carrier; rapid ?sloughing off? of the induced tan from the affected areas; psoriasis; eczema
03/23/1999US5885241 Treatment with an electrically-activated substance
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2173457C Use of 5-alpha reductase inhibitorsand compositions for treating androg enic alopecia
03/23/1999CA2142671C Composition for enhancing hair growth
03/23/1999CA2092794C Naphthylalkylamines, process for their preparation and pharmaceutical compositions that contain them
03/23/1999CA2031505C Phospholipid derivative
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901462A1 Bi-aromatic compounds, compositions containing them and uses
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901377A1 Acne treatment
03/17/1999EP0779076A4 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/17/1999EP0766510B1 Use of a commiphora mukul extract as a pigmenting agent
03/17/1999EP0737070A4 Vitamin d 3? analogues and pathway to mediate disorders
03/17/1999EP0678087B1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
03/17/1999EP0644766B1 Nitrous oxide containing dermatological composition
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211191A Gel formulations containing growth factors
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1211178A Method of inhibiting photoaging of skin
03/17/1999CN1211177A Compositions containing an antifungal and a sulfur compound
03/17/1999CN1210721A Medicine for burn and its preparing process
03/17/1999CN1210714A Cosmetics containing hydroquinone mono aliphatic ester and glycyrrhizin
03/16/1999US5883128 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883114 Indolocarbazole imides and the use thereof
1 ... 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 ... 1065